Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

Cited by (665)

Items 101–200 of 665

1. The Impact of Prostate Cancer Treatment on Quality of Life: A Narrative Review with a Focus on Randomized Data
   James M. Taylor, Victor E. Chen, C. Ryan Miller, Benjamin A. Greenberger · 2020 · Research and Reports in Urology
2. Suspended CNTs/MoS2 heterostructure field effect transistor for high performance biosensor and its application for serum PSA detection
   Junqing Wei, Zihao Liu, Zhuyu Zhang, Kuibo Lan, Yong Wang, Ruibing Chen, Guoxuan Qin · 2023 · Sensors and Actuators B Chemical
3. ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer
   Nina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Malcolm David Mason, Nicolas Mottet, Karel A. Hinnen, Gert De Meerleer, C. Cozzarini, P. Maingon, Ann M. Henry, Martin Spahn et al. · 2023 · Radiotherapy and Oncology
4. Phase 1 Trial of SBRT to the Prostate Fossa After Prostatectomy
   Leslie Ballas, Chunqiao Luo, Eugene Chung, Amar Upadhyaya Kishan, Igor Shuryak, David I. Quinn, Tanya Barauskas Dorff, Shamim Jhimlee, Raymond Chiu, Andre Luis Abreu et al. · 2019 · International Journal of Radiation Oncology*Biology*Physics
5. Intention-to-Treat Analysis of 68Ga-PSMA and 11C-Choline PET/CT Versus CT for Prostate Cancer Recurrence After Surgery
   Johannes Schwenck, Susann-Cathrin Olthof, Christina Pfannenberg, Gerald Reischl, Daniel Wegener, Jolanta Marzec, Jens Bedke, Arnulf Stenzl, Konstantin Nikolaou, Christian Jean la Fougère et al. · 2019 · Journal of Nuclear Medicine
6. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial
   Rhonda Lynn Bitting, Patrick N Healy, Daniel J. George, Monika Anand, Sung Kim, Tina M. Mayer, Carolyn Winters, Colleen Riggan, Julia Rasmussen, Rhonda Wilder et al. · 2020 · European Urology Oncology
7. Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review
   Vérane Achard, Marta Bottero, M. Rouzaud, Andrea Lancia, Marta Scorsetti, Andrea Riccardo Filippi, Ciro Franzese, Barbara Alicja Jereczek‐Fossa, Gianluca Ingrosso, Piet Ost et al. · 2020 · Acta Oncologica
8. Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors
   Simon Chowdhury, Paul N. Mainwaring, Liangcai Zhang, Suneel Dinkar Mundle, Eneida Pollozi, Alexander Gray, Mark A. Wildgust · 2020 · Frontiers in Oncology
9. Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
   Paul Rogowski, Christian Trapp, Rieke von Bestenbostel, Chukwuka Eze, Ute Ganswindt, Minglun Li, Marcus Unterrainer, Mathias Johannes Zacherl, Harun Ilhan, Leonie Beyer et al. · 2021 · European Journal of Nuclear Medicine and Molecular Imaging
10. Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)†
    Akira Yokomizo, Masashi Wakabayashi, Takefumi Satoh, Katsuyoshi Hashine, Takahiro Inoue, Kiyohide Fujimoto, Shin Egawa, Tomonori Habuchi, Kiyotaka Kawashima, Osamu Ishizuka et al. · 2019 · European Urology
11. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy
    Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (DKG-ARO), Ghadjar, Pirus, Aebersold, Daniel M., Albrecht, Clemens, Böhmer, Dirk, Flentje, Michael, Ganswindt, Ute, Höcht, Stefan, Hölscher, Tobias, Sedlmayer, Felix et al. · 2018 · Strahlentherapie und Onkologie
12. Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival
    Detlef Bartkowiak, Reinhard Thamm, Dirk Bottke, Alessandra D. Siegmann, Dirk Böhmer, Volker Budach, Thomas Wiegel · 2017 · Acta Oncologica
13. Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development
    Yan Jennifer Gu, Mathilda Jing Chow, Anil Kapoor, Wenjuan Mei, Yanzhi Jiang, Judy Yan, Jason De Melo, Maryam Seliman, Huixiang Yang, Jean‐Claude Cutz et al. · 2018 · Translational Oncology
14. Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
    Amar Upadhyaya Kishan, Robert Jeffrey Karnes, Tahmineh Romero, Jessica Karen Wong, Giovanni Motterle, Jeffrey J. Tosoian, Bruce J. Trock, Eric A. Klein, Bradley J. Stish, Robert Timothy Dess et al. · 2021 · JAMA Network Open
15. RETRACTED ARTICLE: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
    Boya Zhang, Mingpeng Zhang, Yanjie Yang, Qi Li, Jianpeng Yu, Shimiao Zhu, Yuanjie Niu, Zhiqun Shang · 2021 · Oncogene · Retracted
16. Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601
    Will Jackson, Ming Tang, Matthew J. Schipper, Howard Mark Sandler, Zachary Stephan Zumsteg, Jason Alexander Efstathiou, William U. Shipley, Wendy F. Seiferheld, Himanshu R. Lukka, Jean-Paul Bahary et al. · 2022 · Journal of Clinical Oncology
17. Patterns of relapse as determined by 68Ga-PSMA ligand PET/CT after radical prostatectomy
    Christoph Henkenberens, Thorsten Derlin, Frank Michael Bengel, Tobias L. Roß, Hans‐Jürgen Wester, Katja Hueper, Markus Antonius Kuczyk, Hans Christiansen, Christoph A. von Klot · 2017 · Strahlentherapie und Onkologie
18. Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review
    Adam Benjamin Weiner, Preeti Kakani, Andrew J. Armstrong, Alberto Bossi, Philip A Cornford, Felix Yi-Chung Feng, Pratik Kanabur, Robert Jeffrey Karnes, Rana R. McKay, Todd Matthew Morgan et al. · 2024 · European Urology
19. Antagonizing CD105 enhances radiation sensitivity in prostate cancer
    Anisha Madhav, Allen M. Andres, Frank L. Duong, Rajeev Mishra, Subhash Haldar, Zhenqiu Liu, Bryan Angara, Roberta A. Gottlieb, Zachary Stephan Zumsteg, Neil A. Bhowmick · 2018 · Oncogene
20. Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate Cancer
    Matthew Pierre Deek, Phuoc Tho Tran · 2020 · The Cancer Journal
21. Astragalus polysaccharide inhibits radiation-induced bystander effects by regulating apoptosis in Bone Mesenchymal Stem Cells (BMSCs)
    Yiming Zhang, Liying Zhang, Heng Zhou, Yangyang Li, Kong-Xi Wei, Chenghao Li, Ting Zhou, Jufang Wang, Wen-Jun Wei, Junrui Hua et al. · 2020 · Cell Cycle
22. Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival
    Ken Chow, Justin Bedő, Andrew Ryan, Dinesh Kumar Agarwal, Damien Michael Bolton, Yee Chan, Philip Ellard Dundee, Mark Frydenberg, Marc Alain Furrer, Jeremy R. Goad et al. · 2021 · European Journal of Cancer
23. Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018
    Laura Marandino, Emmanuele De Luca, Clizia Zichi, Pasquale Lombardi, Maria Lucia Reale, Daniele Pignataro, Rosario Francesco Di Stefano, Eleonora Ghisoni, Annapaola Mariniello, Elena Trevisi et al. · 2019 · Clinical Genitourinary Cancer
24. A novel mouse model of human prostate cancer to study intraprostatic tumor growth and the development of lymph node metastases
    Johannes Linxweiler, Christina Körbel, Andreas Müller, Markus Hammer, Christian Veith, Rainer Maria Bohle, Michael Stöckle, Kerstin Junker, Michael Dieter Menger, Matthias Saar · 2018 · The Prostate
25. LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis
    Jianghong Hu, Guohua Ni, Ling Mao, Xianglong Xue, Jijie Zhang, Weixia Wu, Shaoru Zhang, Hong Zhao, Lifang Ding, Lihui Wang · 2019 · OncoTargets and Therapy
26. Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
    Ann-Kathrin Oehus, Stephanie G. C. Kroeze, Nina-Sophie Schmidt-Hegemann, Marco M. E. Vogel, Simon Kirste, Jessica Becker, Irene Andrea Burger, Thorsten Derlin, Peter Bartenstein, Matthias J. Eiber et al. · 2020 · BMC Cancer
27. The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy
    Sonja Adebahr, Alexander Althaus, Sophia Scharl, Iosif Strouthos, Andrea Farolfi, Francesca Serani, Helena Lanzafame, Christian Trapp, Stefan Alexander Koerber, Jan C. Peeken et al. · 2023 · European Journal of Nuclear Medicine and Molecular Imaging
28. A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers
    Philipp Y. Maximov, Balkees Abderrahman, Ramona F. Curpan, Yousef MohammedRabaa Hawsawi, Ping Fan, V. Craig Jordan · 2017 · Endocrine Related Cancer
29. Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence
    Yanzhi Jiang, Wenjuan Mei, Yan Jennifer Gu, Xiaozeng Lin, Lizhi He, Hui Zeng, Fengxiang Wei, Xinhong Wan, Huixiang Yang, Pierre P Major et al. · 2018 · Molecular Oncology
30. Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer
    Francesco Cuccia, Luca Nicosia, Rosario Mazzola, Vanessa Figlia, Niccolò Giaj‐Levra, Francesco Ricchetti, Michele Rigo, Claudio H. Vitale, Stefanie Corradini, Ruggero Ruggieri et al. · 2020 · Strahlentherapie und Onkologie
31. Cancer‑related fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction
    Li Feng, Brian S. Wolff, Josephine K. Liwang, Jeniece M. Regan, Sarah A. Alshawi, Sumiyya A. Raheem, Leorey N. Saligan · 2019 · International Journal of Molecular Medicine
32. Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations
    Deborah Mukherji, Bassem Youssef, Christelle Dagher, Albert El Hajj, Rami Wajih Nasr, Fadi B. Geara, Danny Munther Rabah, Saad Al Dousari, Rabih Said, Raja Ashou et al. · 2019 · World Journal of Urology
33. Low‐dose‐rate brachytherapy for prostate cancer: A 15‐year experience in Japan
    Nobumichi Tanaka, Isao Asakawa, Masatoshi Hasegawa, Kiyohide Fujimoto · 2019 · International Journal of Urology
34. Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy
    Adam Benjamin Weiner, Farzana A. Faisal, Elai Davicioni, Robert Jeffrey Karnes, Donald J. Vander Griend, Tamara Levin Lotan, Edward Matthew Schaeffer · 2020 · European Urology Oncology
35. KEYNOTE-991: Pembrolizumab Plus Enzalutamide and Androgen Deprivation for Metastatic Hormone-Sensitive Prostate Cancer
    Christian Gratzke, Mariusz Kwiatkowski, Ugo De Giorgi, Karine Martins da Trindade, Maria De Santis, Andrew J. Armstrong, Cuizhen Niu, Yingjie Liu, Christian Heinrich Poehlein · 2022 · Future Oncology
36. Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study
    Sophia Scharl, Constantinos Zamboglou, Iosif Strouthos, Andrea Farolfi, Francesca Serani, Helena Lanzafame, ALESSIO GIUSEPPE MORGANTI, Christian Trapp, Stefan Alexander Koerber, Jürgen Debus et al. · 2023 · Radiotherapy and Oncology
37. Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
    Xiaoxiao Lin, Guomin Wu, Shuai Wang, Jinyu Huang · 2023 · Frontiers in Pharmacology
38. The role of radiotherapy in localised and locally advanced prostate cancer
    M. Bolla, Ann M. Henry, Malcom Mason, Thomas Wiegel · 2019 · Asian journal of urology
39. Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study
    Nicola Fossati, Daniele Robesti, Robert Jeffrey Karnes, Matteo Soligo, Stephen Anthony Boorjian, Alberto Bossi, Gabriele Coraggio, Nadia Gisella Di Muzio, C. Cozzarini, B. Noris Chiorda et al. · 2019 · European Urology
40. Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial
    John L. Gore, Marguerite du Plessis, Jingbin Zhang, Darlene Liying Dai, Darby J. S. Thompson, Lawrence Ivan Karsh, Brian R. Lane, MICHAEL E. FRANKS, David Y.T. Chen, Fernando J. Bianco et al. · 2019 · Practical Radiation Oncology
41. CACA guidelines for holistic integrative management of prostate cancer
    Bo Dai, Hongkai Wang, Benkang Shi, Jinchun Xing, Shaoxing Zhu, Zhisong He, Qing Zou, Qiang Wei, Jianbin Bi, Jiasheng Bian et al. · 2024 · Holistic Integrative Oncology
42. Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers
    Dong Fang, Liqun Zhou · 2019 · Asia-Pacific Journal of Clinical Oncology
43. Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials.
    A. Trinchieri, G. Perletti, V. Magri, K. Stamatiou, Margherita Trinchieri, E. Montanari · 2021 · Archivio Italiano di Urologia e Andrologia
44. Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer
    Dirk Bottke, Detlef Bartkowiak, Alessandra D. Siegmann, Reinhard Thamm, Dirk Böhmer, Volker Budach, Thomas Wiegel · 2018 · Prostate Cancer and Prostatic Diseases
45. Patterns of recurrence after prostate bed radiotherapy
    Douglas H. Brand, Joanna I. Parker, David Paul Dearnaley, Rosalind A. Eeles, Robert Anthony Huddart, Vincent S Khoo, Julia R. Murray, Yae‐Eun Suh, Alison Claire Tree, Nicholas J. van As et al. · 2019 · Radiotherapy and Oncology
46. The impact of prostate‐specific antigen persistence after radical prostatectomy on the efficacy of salvage radiotherapy in patients with primary N0 prostate cancer
    Detlef Bartkowiak, Alessandra D. Siegmann, Dirk Böhmer, Volker Budach, Thomas Wiegel · 2019 · British Journal of Urology
47. Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
    Pernelle Lavaud, Clément Dumont, Constance Thibault, Laurence K. Albiges, Giulia Baciarello, Émeline Colomba, Ronan Flippot, Alina Cristina Fuerea, Yohann Loriot, Karim S. Fizazi · 2020 · Therapeutic Advances in Medical Oncology
48. Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance
    David Dewei Yang, Brandon Arvin Virgil Mahal, Vinayak Muralidhar, Marie E. Vastola, Ninjin Boldbaatar, Shelby A. Labe, Michelle Daniel Nezolosky, Peter F. Orio, Martin T. King, Neil E. Martin et al. · 2017 · Clinical Genitourinary Cancer
49. Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study
    Huanyi Lin, Qilong Liu, Xianshang Zeng, Weiguang Yu, Guixing Xu · 2021 · BMC Cancer
50. Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer
    Salvatore Cozzi, Andrea Botti, Giorgia Timon, Gladys Blandino, Masoumeh Najafi, Moana Manicone, Lilia Bardoscia, Maria Paola Ruggieri, Patrizia Ciammella, Cinzia Iotti · 2021 · Strahlentherapie und Onkologie
51. Morphologic spectrum of treatment-related changes in prostate tissue and prostate cancer: an updated review
    Katrina Collins, Liang Cheng C · 2022 · Human Pathology
52. Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents
    Jinge Zhao, Junru Chen, Guangxi Sun, Pengfei Shen, Hao Zeng · 2024 · Cancer Biology and Medicine
53. Aromatase-induced endogenous estrogen promotes tumour metastasis through estrogen receptor-α/matrix metalloproteinase 12 axis activation in castration-resistant prostate cancer
    Zhixian Liang, Jiasong Cao, Lei Tian, Yongmei Shen, Yang Xu, Qimei Lin, Ran Zhang, Haitao Liu, Xiaoling Du, Jiandang Shi et al. · 2019 · Cancer Letters
54. FAM84B promotes prostate tumorigenesis through a network alteration
    Yanzhi Jiang, Xiaozeng Lin, Anil Kapoor, Lizhi He, Fengxiang Wei, Yan Jennifer Gu, Wenjuan Mei, Kuncheng Zhao, Huixiang Yang, Damu Tang · 2019 · Therapeutic Advances in Medical Oncology
55. Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice
    Cédric Michael Panje, Thomas Zilli, Alan Dal Pra, Winfried Arnold, Kathrin Brouwer, Helena I. Garcia Schüler, Silvia Gómez, Fernanda Gabriela Herrera, K. Khanfir, Alexandros Papachristofilou et al. · 2019 · Radiation Oncology
56. Ten-year disease progression and mortality rates in men who experience biochemical recurrence versus persistence after radical prostatectomy and undergo salvage radiation therapy: A post-hoc analysis of RTOG 9601 trial data
    Akshay Sood, Jacob Keeley, Isaac Palma‐Zamora, Sohrab Arora, Deepansh Dalela, Phil Olson, Renee Hanna, Daniel Cotter, Wooju Jeong, Mohamed A. Elshaikh et al. · 2020 · Urologic Oncology Seminars and Original Investigations
57. Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)
    Michael J. Morris, José Maurício Mota, Kristine Peregrino Lacuna, Patrick D. Hilden, Martin Edwin Gleave, Michael Anthony Carducci, Fred Saad C, Erica Simone Dayan, Julie Filipenko, Glenn Heller et al. · 2021 · European Urology Oncology
58. Nationwide Survey of Patients’ Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences
    Narek Shaverdian, Debra Nana Yeboa, Liz Gardner, Paul M. Harari, Kai-Ping Eric Liao, Susan Ann McCloskey, Richard Tuli, Neha Vapiwala, Reshma Jagsi · 2019 · Journal of Oncology Practice
59. How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy
    Alessandro Sciarra, Valerio Santarelli, Stefano Salciccia, Martina Moriconi, Greta Basile, Loreonzo Santodirocco, Dalila Carino, Marco Frisenda, Giovanni Battista Di Pierro, Francesco Del Giudice et al. · 2024 · Cancers
60. Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Jochen Christoph Walz, Gerhardt Attard, Anders Bjartell, Pierre Blanchard, Elena Castro, Éva Compérat, Louise Emmett, Stefano Fanti, V. Fonteyne, S. Foulon et al. · 2025 · Annals of Oncology
61. Travel Distance as a Barrier to Receipt of Adjuvant Radiation Therapy After Radical Prostatectomy
    David Dewei Yang, Vinayak Muralidhar, Brandon Arvin Virgil Mahal, Clair J. Beard, Kent William Mouw, Neil E. Martin, Peter F. Orio, Martin T. King, Paul Linh Nguyen · 2017 · American Journal of Clinical Oncology
62. Surrogate endpoints in early prostate cancer research
    Scott Williams · 2018 · Translational Andrology and Urology
63. Cardiovascular Complications in Patients with Prostate Cancer: Potential Molecular Connections
    Sooraj Kakkat, Paramahansa Pramanik, Seema Singh, Ajay P. Singh, Chandrani Sarkar, Debanjan Chakroborty · 2023 · International Journal of Molecular Sciences
64. The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions
    Makito Miyake, Nobumichi Tanaka, Isao Asakawa, Takuya Owari, Shunta Hori, Yosuke Morizawa, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto et al. · 2018 · Prostate International
65. Sensitization of prostate cancer to radiation therapy: Molecules and pathways to target
    Yao Mu, Linda Joanne Rogers, Natalka Suchowerska, Daniel J. Choe, Mahmoud A. Al‐Dabbas, Ramit S. Narula, James Guy Lyons, Paul D. Sved, Li Zhong, Qihan Dong · 2018 · Radiotherapy and Oncology
66. 68Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy
    S.H. Tan Janice, Xavier Charles, Sin Koh Yen, Li Youquan, Jeffrey K. L. Tuan, Eu Tiong Chua, W.K. Tan Terence, L.C. Wang Michael, Shiong Lee Lui, Kae Jack Tay et al. · 2019 · Cancer Biology and Medicine
67. PSMA PET predicts metastasis-free survival in the setting of salvage radiotherapy after radical prostatectomy
    Mike Wenzel, R. Mohammed Hussein, Tobias Maurer, Pierre I. Karakiewicz, Derya Tilki A, Markus Graefen, Christoph Würnschimmel · 2021 · Urologic Oncology Seminars and Original Investigations
68. Association of Androgen Deprivation Therapy and Thromboembolic Events: A Systematic Review and Meta-analysis
    Kevin Thomas Nead, Ninjin Boldbaatar, David Dewei Yang, Sumi Sinha, Paul Linh Nguyen · 2018 · Urology
69. Current Management of pT3b Prostate Cancer After Robot-assisted Laparoscopic Prostatectomy
    Filip Poelaert, Steven Joniau, Thierry Roumeguère, Filip Ameye, Greet De Coster, Peter Dekuyper, Thierry Quackels, Ben Van Cleynenbreugel, Nancy Van Damme, E. Van Eycken et al. · 2018 · European Urology Oncology
70. Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials
    A. Dal Pra, Pirus Ghadjar, Hyunnam Monica Ryu, J.A. Proudfoot, Stefanie Hayoz, J.M. Michalski, D.E. Spratt, Y. Liu, Corinne Schär, Alejandro Berlín et al. · 2025 · Annals of Oncology
71. Crinum jagus (J. Thomps. Dandy): Antioxidant and protective properties as a medicinal plant on toluene-induced oxidative stress damages in liver and kidney of rats
    Mariama Salihu, Gaber El‐Saber Batiha, Keneth Iceland Kasozi, George D. Zouganelis, Souty M.Z. Sharkawi, Eman Ibrahim Ahmed, Ibe Michael Usman, Halima Nalugo, Juma John Ochieng, Ibrahim Ssengendo et al. · 2022 · Toxicology Reports
72. Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer
    Wanling Xie, Praful Kumar Ravi, Marc E Buyse, Susan Halabi, Philip W. Kantoff, Oliver A. Sartor, Howard R. Soule, Noel William Clarke, James J. Dignam, Nicholas David James et al. · 2023 · Annals of Oncology
73. Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis
    David Eugenio Hinojosa-Gonzalez, Affan Zafar, Gal Saffati, Shane Kronstedt, Dimitar V. Zlatev, Mohit Khera · 2024 · Prostate Cancer and Prostatic Diseases
74. Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
    Sarah Burdett, David J. Fisher, Jayne F. Tierney, Adrian David Cook, Daniel Eidelberg Spratt, James J. Dignam, Wendy F. Seiferheld, Amar Upadhyaya Kishan, Yilun Sun, Sylvie Chabaud et al. · 2025 · European Urology
75. Natural history of ‘second’ biochemical failure after salvage radiation therapy for prostate cancer: a multi‐institution study
    Vasu Tumati, Will Jackson, Ahmed E. Abugharib, Ganesh V. Raj, Claus G. Roehrborn, Yair Lotan, Kevin Dale Courtney, Aditya Bagrodia, Jeffrey C. Gahan, Zachary Stephan Zumsteg et al. · 2017 · British Journal of Urology
76. Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy
    Alan Dal Pra, Cédric Michael Panje, Thomas Zilli, Winfried Arnold, Kathrin Brouwer, Helena I. Garcia Schüler, Markus Glatzer, Silvia Gómez, Fernanda Gabriela Herrera, K. Khanfir et al. · 2017 · Strahlentherapie und Onkologie
77. Initial report of the genitourinary and gastrointestinal toxicity of post-prostatectomy proton therapy for prostate cancer patients undergoing adjuvant or salvage radiotherapy
    Curtiland Deville, Akansha Jain, Wei‐Ting Hwang, Kristina Demas Woodhouse, Stefan Both, Shiyu Wang, Peter Edward Gabriel, John Paul Christodouleas, Justin E. Bekelman, Zelig A Tochner et al. · 2018 · Acta Oncologica
78. Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer
    Robert Timothy Dess, Todd Matthew Morgan, Paul Linh Nguyen, Rohit Mehra, Howard Mark Sandler, Felix Yi-Chung Feng, Daniel Eidelberg Spratt · 2017 · Current Urology Reports
79. Partial prostate re-irradiation for the treatment of isolated local recurrence of prostate cancer in patients previously treated with primary external beam radiotherapy: short-term results of a monocentric study
    Fabio Matrone, Alberto Revelant, Giuseppe Fanetti, Jerry Polesel, Paola Chiovati, Michele Avanzo, Filippo De Renzi, Carlotta Benedetta Colombo, Mauro Arcicasa, Antonino De Paoli et al. · 2020 · Neoplasma
80. [Corrigendum] Cancer‑related fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction
    Li Feng, Brian S. Wolff, Josephine K. Liwang, Jeniece M. Regan, Sarah A. Alshawi, Sumiyya A. Raheem, Leorey N. Saligan · 2020 · International Journal of Molecular Medicine
81. Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
    Ursula Maria Vogl, Tomasz M. Beer, Ian D. Davis, Neal D. Shore, Christopher J. Sweeney, Piet Ost, Gerhardt Attard, Alberto Bossi, Johann Sebastian De Bono, Charles G. Drake et al. · 2021 · European Journal of Cancer
82. Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis
    Giulio Francolini, Barbara Alicja Jereczek‐Fossa, Vanessa Di Cataldo, Gabriele Simontacchi, Giulia Marvaso, Sara Gandini, Federica Corso, Lucia Pia Ciccone, Maria Alessia Zerella, Piercarlo Gentile et al. · 2022 · La radiologia medica
83. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532)
    Bertrand F. TOMBAL, Francisco Gómez-Veiga, Alvaro Gomez-Ferrer, Fernando López‐Campos, Piet Ost, Thierry Roumeguère, Bernardo Herrera‐Imbroda, Lionel A. D'Hondt, Magali Quivrin, Paolo Gontero et al. · 2024 · European Urology Oncology
84. Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis
    Nina-Sophie Schmidt Hegemann, Paul Rogowski, Chukwuka Eze, Christian Schäfer, Christian Georg Stief, Sebastian Lang, Simon K. B. Spohn, Rieke Steffens, Minglun Li, Christian Gratzke et al. · 2020 · Cancers
85. A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma
    Zi‐jun Xu, Lijuan Xu, Liping Liu, Hai Li, Jiewen Jin, Miaoguan Peng, Yanrui Huang, Haipeng Xiao, Yanbing Li, Hongyu Guan · 2021 · Frontiers in Oncology
86. Molecular Genetics of Prostate Cancer and Role of Genomic Testing
    Dilara Akhoundova, Felix Yi-Chung Feng, Colin C. Pritchard, Mark A. Rubin · 2022 · Surgical pathology clinics
87. Molecular Imaging of Recurrent and Metastatic Prostate Cancer
    Robert E. Ware, Scott Williams, Rodney J. Hicks · 2019 · Seminars in Nuclear Medicine
88. Impact of advanced radiotherapy techniques and dose intensification on toxicity of salvage radiotherapy after radical prostatectomy
    Natsuo Tomita, Kaoru Uchiyama, Tomoki Mizuno, Mikiko Imai, Chikao SUGIE, Shiho Ayakawa, Masanari Niwa, Tooru Matsui, S. Otsuka, Yoshihiko Manabe et al. · 2020 · Scientific Reports
89. Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair
    Cameron Herberts, Alexander William Wyatt, Paul Linh Nguyen, Heather H. Cheng · 2023 · American Society of Clinical Oncology Educational Book
90. Prostate Cancer
    Adam Benjamin Weiner, SHILAJIT D. KUNDU · 2017 · Medical Clinics of North America
91. Salvage Radiotherapy for Prostate Cancer
    Kato Rans, Charlien Berghen, Steven Joniau, Gert De Meerleer · 2020 · Clinical Oncology
92. Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer
    Sean Sachdev, Peter R. Carroll, Howard Mark Sandler, Paul Linh Nguyen, Q. Eileen Wafford, Gregory B. Auffenberg, Edward Matthew Schaeffer, Mack Roach, Christopher P. Evans, Maha Hussain · 2020 · JAMA Oncology
93. Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series
    Giulio Francolini, Beatrice Detti, M. Bottero, Thomas Zilli, Andrea Lancia, Alessio Bruni, Simona Borghesi, Matteo Mariotti, Paolo Castellucci, Stefano Fanti et al. · 2020 · Clinical & Translational Oncology
94. Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using 11 C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging
    Avinash K. Nehra, William P. Parker, Rimki Haloi, Sean S. Park, Lance A. Mynderse, Val J. Lowe, Brian J. Davis, Jorge Fernando Quevedo, Geoffrey Bates Johnson, Eugene D. Kwon et al. · 2017 · The Journal of Urology
95. Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database
    Jennifer Beebe‐Dimmer, Julie J. Ruterbusch, Lauren C. Bylsma, Christina N. Gillezeau, Jon P. Fryzek, Neil M. Schultz, Scott C. Flanders, Arie Barlev, Elisabeth I. Heath, Ruben G.W. Quek · 2018 · Advances in Therapy
96. Androgen Deprivation Therapy and Salvage Radiotherapy: Are We Missing Something?
    Carmen González San Segundo, Felipe Couñago, Alfonso Gomez Iturriaga · 2019 · European Urology
97. Prostate re-irradiation: current concerns and future perspectives
    Francesco Cuccia, Rosario Mazzola, Luca Nicosia, Niccolò Giaj‐Levra, Vanessa Figlia, Francesco Ricchetti, Michele Rigo, Claudio H. Vitale, Stefanie Corradini, Filippo Alongi · 2020 · Expert Review of Anticancer Therapy
98. Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study
    Simon Kirste, Stephanie G. C. Kroeze, Christoph Henkenberens, Nina-Sophie Schmidt-Hegemann, Marco M. E. Vogel, Jessica Becker, Constantinos Zamboglou, Irene Andrea Burger, Thorsten Derlin, Peter Bartenstein et al. · 2021 · Frontiers in Oncology
99. Efficacy and Toxicity of Whole Pelvic Radiotherapy Versus Prostate-Only Radiotherapy in Localized Prostate Cancer: A Systematic Review and Meta-Analysis
    Shilin Wang, Wen Tang, Huanli Luo, Fu Jin, Ying Wang · 2022 · Frontiers in Oncology
100. Adjuvant or Salvage Radiation Therapy for Prostate Cancer after Prostatectomy: Current Status, Controversies and Perspectives
     Mario Terlizzi, Elaine Johanna Limkin, Yasmina Moukasse, Pierre Blanchard · 2022 · Cancers